Skip to main content
ARS Home » Pacific West Area » Davis, California » Western Human Nutrition Research Center » Obesity and Metabolism Research » Research » Publications at this Location » Publication #392673

Research Project: Improving Public Health by Understanding Metabolic and Bio-Behavioral Effects of Following Recommendations in the Dietary Guidelines for Americans

Location: Obesity and Metabolism Research

Title: The dose-response effects of consuming high fructose corn syrup-sweetened beverages on hepatic lipid content and insulin sensitivity in young adults

Author
item SIGALA, DESIREE - University Of California, Davis
item HIERONIMUS, BETTINA - University Of California, Davis
item MEDICI, VALENTINA - University Of California, Davis
item LEE, VIVIEN - University Of California, Davis
item NUNEZ, MARINELLE - University Of California, Davis
item BREMER, ANDREW - University Of California, Davis
item COX, CHAD - California State University
item PRICE, CANDICE - University Of California, Davis
item BENYAM, YANET - University Of California, Davis
item ABDELHAFEZ, YASSER - University Of California, Davis
item MCGAHAN, JOHN - University Of California, Davis
item Keim, Nancy
item GORAN, MICHAEL - Children'S Hospital Los Angeles
item PARCINI, GIOVANNI - Consiglio Nazionale Delle Ricerche
item TURA, ANDREA - Consiglio Nazionale Delle Ricerche
item SIRLIN, CLAUDE - University Of California, San Diego
item CHAUDHARI, ABHIJIT - University Of California, Davis
item HAVEL, PETER - University Of California, Davis
item STANHOPE, KIMBER - University Of California, Davis

Submitted to: Nutrients
Publication Type: Peer Reviewed Journal
Publication Acceptance Date: 4/10/2022
Publication Date: 4/15/2022
Citation: Sigala, D.M., Hieronimus, B., Medici, V., Lee, V., Nunez, M.V., Bremer, A.A., Cox, C.L., Price, C.A., Benyam, Y., Abdelhafez, Y., Mcgahan, J.P., Keim, N.L., Goran, M., Parcini, G., Tura, A., Sirlin, C.B., Chaudhari, A.J., Havel, P.J., Stanhope, K.L. 2022. The dose-response effects of consuming high fructose corn syrup-sweetened beverages on hepatic lipid content and insulin sensitivity in young adults. Nutrients. 14(8). Article 1648. https://doi.org/10.3390/nu14081648.
DOI: https://doi.org/10.3390/nu14081648

Interpretive Summary: There is strong scientific evidence that the consumption of sugar-sweetened beverages increases multiple risk factors for chronic disease. However more information is needed to understand what amount of these beverages is associated with detrimental effects, and to identify key changes in physiology that may contribute to these effects. In this study it was determined that fat accumulated in the liver in just two weeks with a dose of high fructose corn syrup (HFCS) as low as 10% of total caloric intake, and at higher HFCS doses of 17.5% and 25% of caloric intake more liver fat accumulated as dose increased. This HFCS dose response of liver fat coincided with measures of poor blood glucose control, also in a dose response manner. These results contribute to the strong and growing body of evidence that increased consumption of sugar-sweetened beverages heightens risk for non-alcoholic fatty liver diseased and type 2 diabetes.

Technical Abstract: Increased hepatic lipid content and decreased insulin sensitivity have critical roles in the development of cardiometabolic diseases. Therefore, our objective was to investigate the dose-response effects of consuming high fructose corn syrup (HFCS)-sweetened beverages for 2 weeks on hepatic lipid content and insulin sensitivity in young (18-40 years) adults (BMI 18-35 kg/m2). In a parallel, double-blinded study, participants consumed 3 beverages/day providing 25% (n=28), 17.5% (n=16), 10% (n=18), or 0% (aspartame: n=23) daily energy requirements from HFCS. Magnetic resonance imaging for hepatic lipid content and oral glucose tolerance tests (OGTT) were conducted during 3.5-day inpatient visits at baseline and again at the end of a 15-day intervention. During the 12 intervening outpatient days participants consumed their usual diets with their assigned beverages. Significant linear dose-response effects were observed for increases of hepatic lipid content (P = 0.015) and OGTT glucose and insulin AUCs during OGTT (both P = 0.0004) and for decreases of the Matsuda (P = 0.0087) and Predicted M (P = 0.0027) indices of insulin sensitivity. These dose-response effects strengthen the mechanistic evidence implicating consumption of sugar-SB as a contributor to the metabolic dysregulation that increases risk for nonalcoholic fatty liver disease and type 2 diabetes.